IQV · Insider Trading
IQVIA Holdings Inc.
Every open-market purchase and sale reported by IQV officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | James G. Berkshire | See Remarks | MIXED | — | −$697.46K |
| 2026-08-04 | W Richard Staub | See Remarks | Sell | −5,500 | −$1.28M |
| 2026-08-04 | Bhavik Patel | See Remarks | Sell | −1,855 | −$436.43K |
| 2026-07-31 | Eric Sherbet | See Remarks | Sell | −5,000 | −$1.25M |
| 2026-07-31 | Keriann Cherofsky | See Remarks | Sell | −558 | −$136.83K |
| 2026-07-31 | Ari Bousbib | See Remarks | MIXED | — | −$26.09M |
| 2026-07-16 | Morris Leslie Wims | Director | A | +148 deriv. | — |
| 2026-07-16 | Jim Fasano | Director | A | +195 deriv. | — |
| 2026-07-16 | John G Danhakl | Director | A | +160 deriv. | — |
| 2026-07-16 | Colleen A Goggins | Director | A | +183 deriv. | — |
| 2026-05-11 | John G Danhakl | Director | A | +185 deriv. | — |
| 2026-05-11 | Jim Fasano | Director | A | +228 deriv. | — |
| 2026-05-11 | Colleen A Goggins | Director | A | +214 deriv. | — |
| 2026-05-11 | Morris Leslie Wims | Director | A | +171 deriv. | — |
| 2026-04-27 | Carol Burt | Director | A | +1,571 | — |
| 2026-04-27 | John G Danhakl | Director | A | +1,571 | — |
| 2026-04-27 | Jim Fasano | Director | A | +1,571 deriv. | — |
| 2026-04-27 | Colleen A Goggins | Director | A | +1,571 | — |
| 2026-04-27 | John M Leonard | Director | A | +1,571 | — |
| 2026-04-27 | William G Kaelin Jr | Director | A | +1,571 deriv. | — |
| 2026-04-27 | Morris Leslie Wims | Director | A | +1,571 deriv. | — |
| 2026-04-27 | Sheila A Stamps | Director | A | +1,571 deriv. | — |
| 2026-02-17 | Michael J. Fedock | See Remarks | F | −123 | −$20.53K |
| 2026-02-17 | Bernd Haas | See Remarks | F | −20 | −$3.34K |
| 2026-02-11 | John G Danhakl | Director | A | +172 deriv. | — |
| 2026-02-11 | Jim Fasano | Director | A | +211 deriv. | — |
| 2026-02-11 | Colleen A Goggins | Director | A | +198 deriv. | — |
| 2026-02-11 | Morris Leslie Wims | Director | A | +159 deriv. | — |
| 2026-02-11 | Ari Bousbib | See Remarks | A | +78,264 deriv. | — |
| 2026-02-11 | James G. Berkshire | See Remarks | A | +11,180 deriv. | — |
| 2026-02-11 | Keriann Cherofsky | See Remarks | A | +2,795 deriv. | — |
| 2026-02-11 | Michael J. Fedock | See Remarks | A | +18,634 deriv. | — |
| 2026-02-11 | Alistair Grenfell | See Remarks | A | +26,088 deriv. | — |
| 2026-02-11 | Bernd Haas | See Remarks | A | +11,180 deriv. | — |
| 2026-02-11 | Bhavik Patel | See Remarks | A | +11,180 deriv. | — |
| 2026-02-11 | Eric Sherbet | See Remarks | A | +12,112 deriv. | — |
| 2026-02-11 | W Richard Staub | See Remarks | A | +26,088 deriv. | — |
| 2026-02-10 | Ari Bousbib | See Remarks | MIXED | +28,778 | −$5.32M |
| 2026-02-10 | James G. Berkshire | See Remarks | MIXED | +1,442 | −$239.99K |
| 2026-02-10 | Ronald E Bruehlman | See Remarks | MIXED | +9,534 | −$1.28M |
| 2026-02-10 | Keriann Cherofsky | See Remarks | MIXED | +672 | −$77.81K |
| 2026-02-10 | W Richard Staub | See Remarks | MIXED | +1,916 | −$151.12K |
| 2026-02-10 | Eric Sherbet | See Remarks | MIXED | +4,891 | −$359.04K |
| 2026-02-10 | Bhavik Patel | See Remarks | MIXED | +2,163 | −$359.98K |
| 2026-02-10 | Michael J. Fedock | See Remarks | MIXED | +4,204 | −$474.54K |
| 2026-02-10 | Alistair Grenfell | See Remarks | MIXED | +6,250 | −$1.04M |
| 2026-02-10 | Bernd Haas | See Remarks | MIXED | +7,825 | −$82.50K |
| 2026-01-30 | Michael J. Fedock | See Remarks | F | −381 | −$91.35K |
| 2025-12-19 | Ari Bousbib | See Remarks | MIXED | — | −$8.13M |
| 2025-11-07 | John G Danhakl | Director | A | +158 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Ari Bousbib | See Remarks | 1,482,361 | $410.07M |
| Ronald E Bruehlman | See Remarks | 62,797 | $17.37M |
| Alistair Grenfell | See Remarks | 29,669 | $8.21M |
| Bernd Haas | See Remarks | 24,394 | $6.75M |
| Eric Sherbet | See Remarks | 20,999 | $5.81M |
| John M Leonard | Director | 16,946 | $4.69M |
| Colleen A Goggins | Director | 14,453 | $4.00M |
| W Richard Staub | See Remarks | 13,312 | $3.68M |
| Michael J. Fedock | See Remarks | 9,472 | $2.62M |
| James G. Berkshire | See Remarks | 8,177 | $2.26M |
| Carol Burt | Director | 7,533 | $2.08M |
| John G Danhakl | Director | 4,245 | $1.17M |
| Keriann Cherofsky | See Remarks | 2,989 | $826.85K |
| Sheila A Stamps | Director | 2,058 | $569.30K |
| Morris Leslie Wims | Director | 2,058 | $569.30K |
| Bhavik Patel | See Remarks | 1,348 | $372.90K |
| Jim Fasano | Director | 1,063 | $294.06K |
| John Connaughton | Director | 1,047 | $289.63K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the IQV quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.